As adcomm looms, ICER raises questions over Lykos’ MDMA studies
The Institute for Clinical and Economic Review said it cannot fairly judge Lykos Therapeutics’ MDMA-assisted therapy for post-traumatic stress disorder because of concerns about certain …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.